Holen Sie sich die Stockscreener-App
1.135
0.44%
0.005
Schlusskurs vom Vortag:
$1.13
Offen:
$1.12
24-Stunden-Volumen:
220.43K
Relative Volume:
0.50
Marktkapitalisierung:
$118.58M
Einnahmen:
$241.52M
Nettoeinkommen (Verlust:
$-199.30M
KGV:
-0.9047
EPS:
-1.2546
Netto-Cashflow:
$37.06M
1W Leistung:
-3.81%
1M Leistung:
-28.62%
6M Leistung:
-72.65%
1J Leistung:
-56.18%
1-Tages-Spanne:
$1.105
$1.175
1-Wochen-Bereich:
$1.105
$1.285
52-Wochen-Spanne:
$1.07
$4.7003
Definitive Healthcare Corp Stock (DH) Company Profile
Firmenname
Definitive Healthcare Corp
Sektor
Branche
Telefon
508-720-4224
Adresse
492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
Compare DH vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DH
Definitive Healthcare Corp
|
1.135 | 118.05M | 241.52M | -199.30M | 37.06M | -1.2546 |
|
VEEV
Veeva Systems Inc
|
179.50 | 29.72B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
50.55 | 8.85B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.18 | 7.42B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.81 | 6.56B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.19 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Definitive Healthcare Corp Stock (DH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-09-17 | Eingeleitet | BTIG Research | Buy |
| 2024-07-31 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-17 | Herabstufung | Needham | Buy → Hold |
| 2024-01-05 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-07-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-04-19 | Eingeleitet | William Blair | Outperform |
| 2022-12-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-07-06 | Eingeleitet | Needham | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-02-24 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-12-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-10-11 | Eingeleitet | Barclays | Equal Weight |
| 2021-10-11 | Eingeleitet | Canaccord Genuity | Hold |
| 2021-10-11 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-11 | Eingeleitet | Deutsche Bank | Hold |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-10-11 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-10-11 | Eingeleitet | Stifel | Buy |
Alle ansehen
Definitive Healthcare Corp Aktie (DH) Neueste Nachrichten
Institution Moves: Is Definitive Healthcare Corp forming a double bottom2026 Selloffs & Entry Point Confirmation Signals - baoquankhu1.vn
Definitive Healthcare stock holds at Neutral as revenue declines persist - Investing.com
Definitive Healthcare (NASDAQ:DH) Cut to Strong Sell at Zacks Research - Defense World
Definitive Healthcare Corp. Hits New 52-Week Low at $1.10 - Markets Mojo
Zacks Research Downgrades Definitive Healthcare (NASDAQ:DH) to Strong Sell - MarketBeat
Gap Down: Can Definitive Healthcare Corp outperform under higher oil pricesJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 - Sahm
Definitive Healthcare (DH) Earnings Transcript - AOL.com
Pullback Watch: Will Definitive Healthcare Corp benefit from current market trendsPortfolio Update Report & Weekly Watchlist of Top Performers - baoquankhu1.vn
Definitive Healthcare Corp. Hits New 52-Week Low at $1.14 - Markets Mojo
Definitive Healthcare Corp. (NASDAQ:DH) Q4 2025 Earnings Call Transcript - Insider Monkey
Definitive Healthcare Earnings Call Balances Profit and Pressure - TipRanks
Canaccord Genuity Group Lowers Definitive Healthcare (NASDAQ:DH) Price Target to $3.00 - Defense World
DH PE Ratio & Valuation, Is DH Overvalued - Intellectia AI
Definitive Healthcare (NASDAQ:DH) Stock Rating Lowered by Wall Street Zen - Defense World
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Stephens cuts Definitive Healthcare stock price target on revenue decline - Investing.com Nigeria
Canaccord Genuity Group Has Lowered Expectations for Definitive Healthcare (NASDAQ:DH) Stock Price - MarketBeat
Definitive Healthcare earnings missed by $0.15, revenue topped estimates - Investing.com South Africa
Stephens Cuts Definitive Healthcare (NASDAQ:DH) Price Target to $2.00 - MarketBeat
Definitive Healthcare Q4 2025 slides: profit gains amid revenue decline - Investing.com Nigeria
Deutsche Bank Adjusts Definitive Healthcare PT to $3 From $6, Maintains Hold Rating - marketscreener.com
Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a 152% Potential Upside Opportunity - DirectorsTalk Interviews
Definitive Healthcare Corp. Q4 2025 Earnings Call Summary - Yahoo Finance
Stephens cuts Definitive Healthcare stock price target on revenue decline By Investing.com - Investing.com India
Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Definitive Healthcare Corp (DH) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges ... By GuruFocus - Investing.com Canada
Definitive Healthcare Q4 Earnings Call Highlights - MarketBeat
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025 - National Today
Definitive Healthcare (NASDAQ:DH) Posts Earnings Results - MarketBeat
Definitive Healthcare Q4 2025 slides: profit gains amid revenue decline By Investing.com - Investing.com South Africa
DH: Revenue and profitability beat guidance, retention improved, and claims data disruption was resolved - TradingView
Definitive Healthcare (NASDAQ:DH) Updates FY 2026 Earnings Guidance - MarketBeat
Definitive Healthcare (NASDAQ:DH) Releases Q1 2026 Earnings Guidance - MarketBeat
Earnings call transcript: Definitive Healthcare Q4 2025 reports revenue beat, EPS miss - Investing.com
Definitive Healthcare Corp. (DH) Matches Q4 Earnings Estimates - Yahoo Finance
DH: Q4 results beat expectations; 2026 outlook cautious but retention and innovation improving - TradingView
Definitive Healthcare Corp. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:DH) 2026-02-26 - Seeking Alpha
Definitive Healthcare Corp. (DH) stock falls on Q4 2025 Earnings - Quiver Quantitative
Definitive Healthcare (DH) CFO receives 733,301 RSU equity award in new grant - Stock Titan
Definitive Healthcare (DH) CEO granted 1.7M RSUs in new equity award - Stock Titan
Definitive Healthcare (NASDAQ: DH) chair awarded 242,719 RSUs vesting 2027 - Stock Titan
Definitive Healthcare (DH) EVP corrects Form 3, discloses 4,045.654 shares - Stock Titan
Definitive Healthcare Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
[8-K] Definitive Healthcare Corp. Reports Material Event | DH SEC FilingForm 8-K - Stock Titan
Definitive Healthcare Corp. Provides Earnings Guidance for the First Quarter and Full Year 2026 - marketscreener.com
Can Definitive Healthcare Corp sustain its profitabilityQuarterly Trade Summary & Weekly Return Optimization Alerts - baoquankhu1.vn
How Definitive Healthcare Corp. stock reacts to global recession fears2025 Market Sentiment & Real-Time Volume Analysis - mfd.ru
Definitive Healthcare Corp. (DH) Stock Analysis: Unveiling The 148% Upside Potential - DirectorsTalk Interviews
Definitive Healthcare (DH) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Analysts Offer Insights on Technology Companies: Leidos Holdings (LDOS), Waystar Holding Corp. (WAY) and Dropbox (DBX) - The Globe and Mail
Finanzdaten der Definitive Healthcare Corp-Aktie (DH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):